Published in Women's Health Weekly, October 20th, 2005
According to recent research from Canada, "Hypoxia that develops in solid tumors stabilizes the hypoxia-inducible factor-1 alpha (HIF-1 alpha) subunit of the HIF-1 transcription factor, leading to up-regulation of dozens of hypoxia-regulated genes that increase glycolysis and oxygen delivery. HIF-1 alpha and its downstream target gene CA9 have both been used as surrogate hypoxia markers, and, in general, high expression predicts for a poor response to treatment."
"Combinations of hypoxia markers offer the opportunity to measure changes in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly